175 related articles for article (PubMed ID: 26754531)
21. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.
van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199
[TBL] [Abstract][Full Text] [Related]
22. 2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.
Pillarsetty N; Punzalan B; Larson SM
J Nucl Med; 2009 Oct; 50(10):1709-14. PubMed ID: 19759108
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging.
Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C
Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431
[TBL] [Abstract][Full Text] [Related]
24. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
25. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
Tsuji AB; Kato K; Sugyo A; Okada M; Sudo H; Yoshida C; Wakizaka H; Zhang MR; Saga T
Nucl Med Commun; 2012 Oct; 33(10):1058-64. PubMed ID: 22797465
[TBL] [Abstract][Full Text] [Related]
27. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
[TBL] [Abstract][Full Text] [Related]
28. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
Sugae S; Suzuki A; Takahashi N; Minamimoto R; Cheng C; Theeraladanon C; Endo I; Togo S; Inoue T; Shimada H
Ann Nucl Med; 2008 Jan; 22(1):65-72. PubMed ID: 18250989
[TBL] [Abstract][Full Text] [Related]
29. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
[TBL] [Abstract][Full Text] [Related]
30. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
[TBL] [Abstract][Full Text] [Related]
31. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
32. A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation.
Huang T; Wang H; Tang G; Liang X; Nie D; Yi C; Wu K
Molecules; 2012 Nov; 17(12):13948-59. PubMed ID: 23183886
[TBL] [Abstract][Full Text] [Related]
33. Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.
Tsao CH; Wu CY; Chang CW; Wang HE; Shih BF; Liu RS
Nucl Med Commun; 2019 Jun; 40(6):639-644. PubMed ID: 30932968
[TBL] [Abstract][Full Text] [Related]
34. In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
Rybczynska AA; de Bruyn M; Ramakrishnan NK; de Jong JR; Elsinga PH; Helfrich W; Dierckx RA; van Waarde A
J Nucl Med; 2013 Sep; 54(9):1613-20. PubMed ID: 23940303
[TBL] [Abstract][Full Text] [Related]
35. Comparative Analysis between [(18)F]Fludarabine-PET and [(18)F]FDG-PET in a Murine Model of Inflammation.
Hovhannisyan N; Dhilly M; Guillouet S; Leporrier M; Barré L
Mol Pharm; 2016 Jun; 13(6):2136-9. PubMed ID: 27080099
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
[TBL] [Abstract][Full Text] [Related]
37. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
38. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
Lu L; Jiang L; Guan H; Gao Y; Lu H
Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
[TBL] [Abstract][Full Text] [Related]
39. PET of glial metabolism using 2-18F-fluoroacetate.
Marik J; Ogasawara A; Martin-McNulty B; Ross J; Flores JE; Gill HS; Tinianow JN; Vanderbilt AN; Nishimura M; Peale F; Pastuskovas C; Greve JM; van Bruggen N; Williams SP
J Nucl Med; 2009 Jun; 50(6):982-90. PubMed ID: 19443600
[TBL] [Abstract][Full Text] [Related]
40. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
